The Business Research Company’s report on the Cardiac Valve Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
How have key drivers contributed to the rapid growth of the cardiac valve market?
The rising incidence of cardiovascular diseases is expected to propel the growth of the cardiac valve market. The prevalence of cardiovascular disease has gradually increased due to smoking, obesity, a lack of physical activity, and other factors that strain the cardiovascular system. The most common cause of coronary artery disease is arteries’ build-up of fatty plaques. These gradual increases in heart-related diseases raised the demand for the cardiac valve to treat heart valve problems. For instance, in September 2023, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, there were 41 million deaths, which is 74% of those caused by non-communicable diseases (NCDs) or chronic diseases every year globally. There were 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2.0 million deaths from diabetes. Therefore, the rising incidence of cardiovascular diseases will drive the growth of the cardiac valve market.
Access Your Free Sample of the Global Cardiac Valve Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=7753&type=smp
How has the cardiac valve market size evolved, and what are the latest forecasts for its expansion?
The cardiac valve market size has grown rapidly in recent years. It will grow from $10.89 billion in 2024 to $12.48 billion in 2025 at a compound annual growth rate (CAGR) of 14.6%. The growth in the historic period can be attributed to aging population and the associated increase in valvular heart disease, growth in the prevalence of risk factors like obesity and hypertension, improved diagnostic and imaging technologies for valve diseases, awareness campaigns and education on heart health and valve disease, and development of minimally invasive and transcatheter valve procedures.
The cardiac valve market size is expected to see rapid growth in the next few years. It will grow to $21.26 billion in 2029 at a compound annual growth rate (CAGR) of 14.2%. The growth in the forecast period can be attributed to increasing demand for bioengineered and tissue-engineered heart valves, aging global population andThe need for valve disease treatment, telemedicine and remote patient monitoring for valve patients, enhanced surgical techniques and robotics-assisted valve procedures, and adoption of 3D printing for personalized heart valve manufacturing. Major trends in the forecast period include advancements in valve replacement and repair techniques, integration of artificial intelligence (ai) for valve disease detection and treatment planning, adoption of 3D printing for personalized heart valve manufacturing, advancements in valve replacement and repair techniques, and enhanced surgical techniques and robotics-assisted valve procedures.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=7753&type=smp
Which major companies dominate the cardiac valve market?
Major companies operating in the cardiac valve market include Abbott Laboratories, Colibri Heart Valve LLC, TTK HealthCare Limited, Artivion Inc., Edwards Lifesciences Corporation, Boston Scientific Corporation, Jenavalve Technology Inc., CryoLife Inc., Lepu Medical Technology Co. Ltd., Braile Biomedical, Sorin Group, Micro Interventional Devices Inc., Medtronic Inc., Lepu Medical Technology, Edward Lifesciences Corporation, Xeltis AG, Meril Life Sciences Pvt. Ltd., Auto Tissue Berlin GmbH, On-X Life Technologies Inc., Thubrikar Aortic Valve Inc., LifeNet Health Inc.
What trends will shape the future of the cardiac pacemakers market?
Technological advancements in cardiac valves are a key trend gaining popularity in the cardiac valve market. With advancements in technology, there are less invasive treatment options for heart diseases. Major companies operating in the cardiac valve market are concentrating on technologies such as neochordae implantation, annuloplasty ring, and robotic surgery to strengthen their market position. These innovative technologies help to protect patients from life-threatening conditions such as heart stroke and cardiac arrest. For instance, in September 2022, Edwards, a US-based medical technology company launched Sapien 3 Ultra Resilia transcatheter heart valve with anti-calcification technology. This technology platform was developed to irreversibly block calcium binding sites in bioprosthetic valves.
Which region dominates the cardiac valve market, and what factors contribute to its leadership?
North America was the largest region in the cardiac valve market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac valve market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Order Your Report Now For Swift Delivery
https://www.thebusinessresearchcompany.com/report/cardiac-valve-global-market-report
How is the cardiac valve market segmented, and which segment holds the largest share?
The cardiac valve market covered in this report is segmented –
1) By Type: Tissue Heart Valves, Transcatheter Heart Valves, Mechanical Heart Valves, Other Types
2) By Position: Aortic Valve, Mitral Valve, Other Positions
3) By Treatment: Cardiac Valve Repair, Cardiac Valve Replacement
4) By End-Users: Hospital And Clinics, Specialty Centers, Cardiac Research Institute, Other End Users
Subsegments:
1) By Tissue Heart Valves: Bioprosthetic Valves (e.g., porcine, bovine), Homograft Valves
2) By Transcatheter Heart Valves: Transcatheter Aortic Valve Implantation (TAVI) Valves, Transcatheter Mitral Valve Repair Valves
3) By Mechanical Heart Valves: Tilting Disc Valves, Bileaflet Valves, Caged Ball Valves
4) By Other Types: Conduits, Stented vs. Stentless Valves
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7753
How is the cardiac valve market defined, and what are its core characteristics?
Cardiac valves refer to artificial valves used to keep the flow of blood in one direction from the heart to the rest of the body parts. A cardiac valve is an implantable device used to replace a damaged body valve that has stopped working due to various diseases. The primary function of the cardiac valve is to keep blood flowing in the proper direction through the heart and from the heart into the major blood vessels connected to it.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
